410
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysis

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jianxin Chen & Junhui Wang. (2018) Efficacy and safety assessment of apatinib in patients with advanced gastric cancer: a meta-analysis. OncoTargets and Therapy 11, pages 4149-4158.
Read now
Omar Abdel-Rahman, Hesham ElHalawani & Shaimaa Essam-Eldin. (2016) S-1-based regimens and the risk of oral and gastrointestinal mucosal injury: a meta-analysis with comparison to other fluoropyrimidines. Expert Opinion on Drug Safety 15:1, pages 5-20.
Read now

Articles from other publishers (4)

Yuji Murakami, Masahiro Kenjo, Kazuki Ishikawa, Toru Sakayauchi, Satoshi Itasaka, Yoshiharu Negoro, Keiichi Jingu, Yasumasa Nishimura, Yasushi Nagata & Kazuhiko Ogawa. (2020) Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents. Journal of Radiation Research 61:4, pages 629-634.
Crossref
Omar Abdel-Rahman, Nermean Bahie Eldin & Hesham ElHalawani. (2016) Risk of selected gastrointestinal and hepatic toxicities in cancer patients treated with nintedanib: a meta-analysis. Future Oncology 12:18, pages 2163-2172.
Crossref
Omar Abdel-Rahman & Mona Fouad. (2016) Rolapitant: a pooled analysis of its efficacy and safety in the prophylaxis of chemotherapy-induced nausea and vomiting. Future Oncology 12:6, pages 871-879.
Crossref
Kai Wang, Xiao Qu, Ying Wang, Wei Dong, Hongchang Shen, Tiehong Zhang, Yang Ni, Qi Liu & Jiajun Du. (2015) The Impact of Ramucirumab on Survival in Patients with Advanced Solid Tumors: A Systematic Review and Meta-Analysis of Randomized II/III Controlled Trials. Clinical Drug Investigation 36:1, pages 27-39.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.